This article will cover the similarities and differences between Farxiga and Jardiance, including their uses, side effects, ...
AstraZeneca’s Farxiga has become the latest type 2 diabetes drug to show it can reduce cardiovascular risk in a clinical trial. Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin ...